Becton, Dickinson and Company

Headquarters: Franklin Lakes, NJ, United States

Founded: East Rutherford, New Jersey 1897

Employees: 75,000

CEO: Mr. Thomas E. Polen Jr.

NYSE: BDX +0.88%

Market Cap

$70.33 Billion

USD as of Jan. 1, 2024

Market Cap History

Company Description

Becton, Dickinson and Company, more simply known as BD, is a medical technology company. It manufactures and markets medical devices, instrument systems, reagents, and provides consulting and analytics services. Founded in 1897, BD was a pioneer of syringes that expanded to other medical supplies such as needles, catheters, and developed a range of medical, diagnostic and research devices.

Becton, Dickinson and Company market capitalization over time

Evolution of Becton, Dickinson and Company market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Becton, Dickinson and Company

Detailed Description

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Top 1-year algo backtest: +298.72%

$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Becton, Dickinson and Company has the following listings and related stock indices.

Stock: NYSE: BDX wb_incandescent

Stock: BMV: BDX wb_incandescent

Stock: Bovespa: B1DX34 wb_incandescent

Stock: NYSE: BDXB wb_incandescent

Stock: XETR: BOX wb_incandescent

Key People

Founder(s): Maxwell Becton and Fairleigh S. Dickinson

Tom Polen (Chairman, CEO and President) Christopher R. Reidy (Executive Vice President and CAO) Christopher Del Orefice (Executive Vice President and CFO)


Revenue: US$20.248 Billion (Fiscal Year Ended September 30, 2021)

Operating income: US$2.799 Billion (Fiscal Year Ended September 30, 2021)

Net income: US$2.002 Billion (Fiscal Year Ended September 30, 2021)

Total assets: US$53.866 Billion (Fiscal Year Ended September 30, 2021)

Total equity: US$23.677 Billion (Fiscal Year Ended September 30, 2021)



1 Becton Drive

Franklin Lakes, NJ 07417-1880

United States

Phone: 201 847 6800